100 related articles for article (PubMed ID: 32626880)
1. [Gefitinib/chloroquine-liposome-microbubble complexes as ultrasound-triggered therapeutic particles for head and neck squamous cell carcinoma in vitro].
Zhou L; Gong X; Xiong P
Shanghai Kou Qiang Yi Xue; 2020 Apr; 29(2):168-173. PubMed ID: 32626880
[TBL] [Abstract][Full Text] [Related]
2. STAT3 decoy oligonucleotide-carrying microbubbles with pulsed ultrasound for enhanced therapeutic effect in head and neck tumors.
Ramasamy T; Chen X; Qin B; Johnson DE; Grandis JR; Villanueva FS
PLoS One; 2020; 15(11):e0242264. PubMed ID: 33206698
[TBL] [Abstract][Full Text] [Related]
3. Ultrasound-mediated gene and drug delivery using a microbubble-liposome particle system.
Yoon YI; Kwon YS; Cho HS; Heo SH; Park KS; Park SG; Lee SH; Hwang SI; Kim YI; Jae HJ; Ahn GJ; Cho YS; Lee H; Lee HJ; Yoon TJ
Theranostics; 2014; 4(11):1133-44. PubMed ID: 25250094
[TBL] [Abstract][Full Text] [Related]
4. Anti-cancer activity of microbubble conjugated with Sorafenib containing liposome and IL4R-targeting peptide in kidney cancer cells.
Lee J; Park SH
Cell Mol Biol (Noisy-le-grand); 2023 Dec; 69(14):266-271. PubMed ID: 38279420
[TBL] [Abstract][Full Text] [Related]
5. Development of a novel microbubble-liposome complex conjugated with peptide ligands targeting IL4R on brain tumor cells.
Park SH; Yoon YI; Moon H; Lee GH; Lee BH; Yoon TJ; Lee HJ
Oncol Rep; 2016 Jul; 36(1):131-6. PubMed ID: 27220374
[TBL] [Abstract][Full Text] [Related]
6. Targeted shRNA-loaded liposome complex combined with focused ultrasound for blood brain barrier disruption and suppressing glioma growth.
Zhao G; Huang Q; Wang F; Zhang X; Hu J; Tan Y; Huang N; Wang Z; Wang Z; Cheng Y
Cancer Lett; 2018 Apr; 418():147-158. PubMed ID: 29339208
[TBL] [Abstract][Full Text] [Related]
7. Paclitaxel-liposome-microbubble complexes as ultrasound-triggered therapeutic drug delivery carriers.
Yan F; Li L; Deng Z; Jin Q; Chen J; Yang W; Yeh CK; Wu J; Shandas R; Liu X; Zheng H
J Control Release; 2013 Mar; 166(3):246-55. PubMed ID: 23306023
[TBL] [Abstract][Full Text] [Related]
8. Combined SN-38 and gefitinib treatment promotes CD44 degradation in head and neck squamous cell carcinoma cells.
Nanbu T; Umemura N; Ohkoshi E; Nanbu K; Sakagami H; Shimada J
Oncol Rep; 2018 Jan; 39(1):367-375. PubMed ID: 29192320
[TBL] [Abstract][Full Text] [Related]
9. [Mechanism of chloroquine in promoting sensitivity of chemotherapeutics in oral squamous cell carcinoma CAL-27 cell line to cisplatin].
Quan HY; Quan HY; Zhou LJ; Li AD; Zhang ZB
Shanghai Kou Qiang Yi Xue; 2015 Feb; 24(1):30-6. PubMed ID: 25858366
[TBL] [Abstract][Full Text] [Related]
10. Release of vascular agonists from liposome-microbubble conjugate by ultrasound-mediated microbubble destruction: effect on vascular function.
Franco-Urquijo CA; Navarro-Becerra JÁ; Ríos A; Escalante B
Drug Deliv Transl Res; 2022 May; 12(5):1175-1186. PubMed ID: 33939122
[TBL] [Abstract][Full Text] [Related]
11. FGFR1 Is a Potential Prognostic Biomarker and Therapeutic Target in Head and Neck Squamous Cell Carcinoma.
Koole K; Brunen D; van Kempen PM; Noorlag R; de Bree R; Lieftink C; van Es RJ; Bernards R; Willems SM
Clin Cancer Res; 2016 Aug; 22(15):3884-93. PubMed ID: 26936917
[TBL] [Abstract][Full Text] [Related]
12. Enhanced antiproliferative effect of resveratrol in head and neck squamous cell carcinoma using GE11 peptide conjugated liposome.
Zheng T; Feng H; Liu L; Peng J; Xiao H; Yu T; Zhou Z; Li Y; Zhang Y; Bai X; Zhao S; Shi Y; Chen Y
Int J Mol Med; 2019 Apr; 43(4):1635-1642. PubMed ID: 30816515
[TBL] [Abstract][Full Text] [Related]
13. [Therapeutic effect of combined use of FGF1-loaded nano-liposomes and ultrasound-targeted microbubble destruction technique on treating rats with experimental diabetic cardiomyopathy].
Zhang M; Zhao YZ; Ma WC; Xu JL; Wang JL; Chen MJ; Yu L; Chen YN
Zhonghua Xin Xue Guan Bing Za Zhi; 2017 May; 45(5):427-433. PubMed ID: 28511329
[No Abstract] [Full Text] [Related]
14. [Effects of N-(4-hydroxyphenyl) retinamide lipid microbubble combined with ultrasound on human keloid fibroblasts].
Wang MJ; Fang YH; Jin CL; Jin ZH
Zhonghua Shao Shang Za Zhi; 2018 Oct; 34(10):683-689. PubMed ID: 30369135
[No Abstract] [Full Text] [Related]
15. Sensitization of multidrug-resistant malignant cells by liposomes co-encapsulating doxorubicin and chloroquine through autophagic inhibition.
Gao M; Xu Y; Qiu L
J Liposome Res; 2017 Jun; 27(2):151-160. PubMed ID: 27250110
[TBL] [Abstract][Full Text] [Related]
16. Localized delivery of Erlotinib using liposomal gel formulations for the treatment of oral squamous cell carcinoma.
Hariharan K; Mehta T; Shah J; Dave H; Sami A; Omri A
Int J Pharm; 2023 Jul; 642():123144. PubMed ID: 37330155
[TBL] [Abstract][Full Text] [Related]
17. Metformin enhances gefitinib efficacy by interfering with interactions between tumor-associated macrophages and head and neck squamous cell carcinoma cells.
Yin X; Han S; Song C; Zou H; Wei Z; Xu W; Ran J; Tang C; Wang Y; Cai Y; Hu Q; Han W
Cell Oncol (Dordr); 2019 Aug; 42(4):459-475. PubMed ID: 31001733
[TBL] [Abstract][Full Text] [Related]
18. Enhanced combination therapy effect on paclitaxel-resistant carcinoma by chloroquine co-delivery via liposomes.
Gao M; Xu Y; Qiu L
Int J Nanomedicine; 2015; 10():6615-32. PubMed ID: 26543365
[TBL] [Abstract][Full Text] [Related]
19. Co-targeting EGFR and IKKβ/NF-κB signalling pathways in head and neck squamous cell carcinoma: a potential novel therapy for head and neck squamous cell cancer.
Li Z; Liao J; Yang Z; Choi EY; Lapidus RG; Liu X; Cullen KJ; Dan H
Br J Cancer; 2019 Feb; 120(3):306-316. PubMed ID: 30585254
[TBL] [Abstract][Full Text] [Related]
20. Intraoperative 186Re-liposome radionuclide therapy in a head and neck squamous cell carcinoma xenograft positive surgical margin model.
Wang SX; Bao A; Herrera SJ; Phillips WT; Goins B; Santoyo C; Miller FR; Otto RA
Clin Cancer Res; 2008 Jun; 14(12):3975-83. PubMed ID: 18559620
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
